Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome

Journal of Clinical Investigation

Volumn 98, Issue 8, 1996, Pages 1888-1896

  Konstantinov, K ^a   Von Mikecz, A ^a   Buchwald, D ^b   Jones, J ^c   Gerace, L ^a   Tan, E M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

autoantibodies; chronic fatigue syndrome; nuclear envelope antigens; nuclear lamins

Indexed keywords

AUTOANTIBODY; CELL NUCLEUS ANTIGEN; COMPLEMENTARY DNA; IMMUNOGLOBULIN G; LAMIN B;

ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL NUCLEUS MEMBRANE; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; RAT; T LYMPHOCYTE;

EID: 0029961385     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118990     Document Type: Article

References (35)

1. Holmes, G.P., J.E. Kaplan, M.M. Gantz, A.L. Komaroff, L.B. Schonberger, S.E. Straus, J.F. Jones, R.E. Dubois, C. Cunningham, J. Rundles, et al. 1988. Chronic fatigue syndrome: a working case definition. Ann. Intern. Med. 108:387-389.
2. Schluederberg, A., S.E. Straus, P. Petersen, S. Blumenthal, A.L. Komaroff, S.B. Spring, A. Landay, and D. Buchwald. 1992. Chronic fatigue syndrome research definition and medical outcome assessment. Ann. Intern. Med. 117:325-333.
3. Fukuda, K., S.E. Straus, I. Hickie, M.C. Sharpe, J.G. Dobbins, A. Komaroff, and the International Chronic Fatigue Syndrome Study Group. 1994. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med. 121:953-959.
4. Buchwald, D., P. Umali, J. Umali, P. Kirth, T. Pearlman, and A.L. Komaroff. 1995. Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system. Ann. Intern. Med. 123:81-88.
5. Subira, M.L., A. Castilla, M.-P. Civeira, and J. Prieto. 1989. Deficient display of CD3 on lymphocytes of patients with chronic fatigue syndrome. J. Infect. Dis. 160:165-166.
6. Klimas, N.G., F.R. Salvato, R. Morgan, and M.A. Fletcher. 1990. Immunologic abnormalities in chronic fatigue syndrome. J. Clin. Microbiol. 28:1403-1410.
7. Straus, S.E., J.K. Dale, J.B. Peter, and C.A. Dinarello. 1989. Circulating lymphocyte levels in chronic fatigue syndrome. J. Infect. Dis. 160:1085-1086.
8. Landay, A.L., C. Jessop, E.T. Lennette, and J.A. Levy. 1991. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet. 338:707-712.
9. Bates, D.W., D. Buchwald, J. Lee, P. Kith, T. Doolittle, C. Rutherford, W. Hallowell, P.H. Schur, M. Wener, D. Wybenga, et al. 1995. Clinical laboratory test findings in patients with chronic fatigue syndrome. Arch. Intern. Med. 155:97-103.
10. Jones, J.F., C.G. Ray, L.L. Minnich, M.J. Hicks, R. Kibler, and D.O. Lucas. 1985. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann. Intern. Med 102:1-7.
11. Straus, S.E., G. Tosato, G. Armstrong, T. Lawley, D.T. Preble, W. Henle, R. Davey, G. Pearson, J. Epstein, I. Brus, and M. Blaese. 1985. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann. Intern. Med. 102:7-16.
12. Calabrese, L.H., M.E. Davis, and W.S. Wilke. 1994. Chronic fatigue syndrome and a disorder resembling Sjogren's syndrome: preliminary report. Clin. Infect. Dis. 18(Suppl. 1):S28-S31.
13. Robins, L.N., and J.E. Helger. 1985. Diagnostic Interview Schedule (DIS): version III-A. St. Louis, Department of Psychiatry, Washington University School of Medicine.
14. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. (revised). Washington, D.C., American Psychiatric Association. 1987.
15. Senior, A., and L. Gerace. 1988. Integral membrane proteins specific to the inner nuclear membrane and associated with the nuclear lamina. J. Cell Biol. 107:2029-2036.
16. Foisner, R., and L. Gerace. 1993. Integral membrane proteins of the nuclear envelope interaction with lamins and chromosomes and binding is modulated by mitotic phosphorylation. Cell. 73:1267-1279.
17. Snow, C.M., A. Senior, and L. Gerace. 1987. Monoclonal antibodies identify a group of nuclear pore complex glycoproteins. J. Cell Biol. 104:1143-1156.
18. Andrade, L.E.C., E.M. Tan, and E.K.L. Chan. 1993. Immunocytochemical analysis of the coiled body in the cell cycle and during cell proliferation. Proc. Natl. Acad. Sci. USA. 90:1947-1951.
19. Pollard, K.M., E.C.L. Chan, B.J. Grant, K.F. Sullivan, E.M. Tan, and C.A. Glass. 1990. In vitro posttranslational modification of lamin B cloned from a human T-cell line. Mol. Cell. Biol. 10:2164-2175.
20. Gerace, L., Y. Ottaviano, and C. Kondor-Koch. 1982. Identification of a major polypeptide of the nuclear pore complex. J. Cell Biol. 95:826-837.
21. Imai, H., K. Furuta, G. Landberg, K. Kiyosawa, L.F. Liu, and E.M. Tan. 1995. Autoantibody to DNA topoisomerase II in primary liver cancer. Clin. Cancer Res. 1:417-424.
22. 4. Nature (Lond.). 227:680-685.
23. Senecal, J.-L., and Y. Raymond. 1992. Autoantibodies to major and minor nuclear lamins are not restricted to autoimmune diseases. Clin. Immunol. Immunopathol. 63:115-125.
24. Konstantinov, K.N., R. Foisner, D. Byrd, F.-T. Liu, W.-M. Tsai, A. Wiik, and L. Gerace. 1995. Integral membrane proteins associated with the nuclear lamina are novel autoimmune antigens of the nuclear envelope. Clin. Immunol. Immunopathol. 74:89-99.
25. Tan, E.M. 1989. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 144:93-151.
26. Worman, H.J., and J.-C. Courvalin. 1991. Autoantibodies against nuclear envelope proteins in liver disease. Hepatology. 14:1269-1279.
27. Courvalin, J.-C., K. Lassoued, H. Worman, and G. Blobel. 1990. Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis. J. Exp. Med. 172:961-967.
28. Courvalin, J.-C., K. Lassoued, E. Bartnik, G. Blobel, and R.W. Wozniak. 1990. The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J. Clin. Invest. 86:279-285.
29. Reeves, W.H., N. Chaudhary, A. Salerno, and G. Blobel. 1987. Lamin B autoantibodies in sera of certain patients with systemic lupus erythematosus. J. Exp. Med. 165:750-762.
30. Konstantinov, K., P. Halberg, A. Wiik, M. Hoier-Madsen, P. Wantzin, S. Ullman, and Z. Galcheva-Gargova. 1992. Clinical manifestations in patients with autoantibodies specific for nuclear lamin proteins. Clin. Immunol. Immunopathol. 62:112-118.
31. Wesierska-Gadek, J., E. Penner, E. Hitchman, and G. Sauerman. 1988. Antibodies to nuclear lamins in autoimmune liver disease. Clin. Immunol. Immunopathol. 19:107-115.
32. Lassoued, K., M.-N. Guilly, F. Danon, C. Andre, D. Dhumeaux, J.-P. Clauvel, J.-C. Brouet, M. Seligman, and J.-C. Courvalin. 1988. Antinuclear antibodies specific for lamins: characterization and clinical significance. Ann. Intern. Med. 108:829-833.
33. Chou, C.-H., S.A. Ali, R. Roubey, J. Buyon, and W.H. Reeves. 1991. Onset and regulation of anti-lamin B autoantibody production is independent of the level of polyclonal activation. Autoimmunity. 8:297-305.
34. Valesini, G., R. Priori, F. Conti, F.L. Luan, C. Ardino, and F. Balsano. 1994. Chronic fatigue syndrome: a peculiar evolution of eosinophilia myalgia syndrome following treatment with L-tryptophan in four Italian adolescents. Eur. J. Pediatr. 153:344-346.
35. Varga, J., G.G. Maul, and S.A. Jimenez. 1992. Autoantibodies to nuclear lamin C in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Arthritis Rheum. 35:106-109.